Brief: Andrew Ratz, Ph.D., Joins Neurocrine Biosciences As Senior Vice President Of Drug Development, Delivery And Device
23/01/2025 22:52
Neurocrine Biosciences Inc NBIX.O :
* ANDREW RATZ, PH.D., JOINS NEUROCRINE BIOSCIENCES AS SENIOR
VICE
PRESIDENT OF DRUG DEVELOPMENT, DELIVERY AND DEVICE
Source text: ID:nPnbWlZvZa
Further company coverage: NBIX.O
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall